Newcells Biotech

PITCH
We believe that combining the “best biology” into 3-D environments is the future of in vitro cell based assays that deliver superior data to support in vitro to in vivo translation. We are experts in induced pluripotent stem cell (iPSC) differentiation and assay construction
LATEST INVESTMENT
#Healthtech
03.2021
£5.25M
Mercia, Northern Venture Capital Trust (VCT) & North East Venture Fund (NEVF) backed by the European Regional Development Fund (ERDF)